final approval in canada should now be little more than a formality analysts said and the company expects full approval for sativex early in 2005. we are delighted to receive this qualifying notice from health canada and look forward to receiving regulatory approval for sativex in canada in the early part of 2005 said gw pharma executive chairman dr geoffrey gu cannabis hopes for drug firm a prescription cannabis drug made by uk biotech firm gw pharmaceuticals is set to be approved in canad a few weeks ago shares in gw pharma lost a third of their value after uk regulators said they wanted more evidence about the drug s benefit this will be the first time a cannabis based drug has been approved anywhere in the world representing a landmark for gw pharma and for patients with m